Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-16-019154
Filing Date
2016-12-05
Accepted
2016-12-05 16:44:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM S-3 fs32016a1_immucellcorp.htm S-3/A 449535
2 OPINION OF PIERCE ATWOOD LLP fs32016a1ex5i_immucellcorp.htm EX-5.1 24588
3 CONSENT OF BAKER NEWMAN & NOYES LLC fs32016a1ex23ii_immucellcorp.htm EX-23.1 3286
4 GRAPHIC image_001.gif GRAPHIC 3509
5 GRAPHIC image_002.jpg GRAPHIC 2425
  Complete submission text file 0001213900-16-019154.txt   486802
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-214641 | Film No.: 162034264
SIC: 2835 In Vitro & In Vivo Diagnostic Substances